Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antimetastatic activity of Ono-4817 in mice bearing head and neck cancer

Oct. 16, 2003

Amgen selects Tularik compounds for optimization under collaboration

Oct. 16, 2003

SAHA receives orphan drug status

Oct. 16, 2003

Novel CRH analogues for use in melanoma therapy designed at the U. of California

Oct. 16, 2003

Several series of HDAC inhibitors described by Janssen

Oct. 16, 2003

Pintex Pharmaceuticals claims Pin1 inhibitors and their use in cancer therapy

Oct. 16, 2003

Selective erbB2 kinase inhibitor CP-654577 inhibits growth of human breast cancer

Oct. 15, 2003

FDA accepts Erbitux BLA for filing

Oct. 14, 2003

Novel VEGFR2 modulators prepared and tested at Pfizer

Oct. 14, 2003

New polyamine is effective and well tolerated in human prostate xenograft models

Oct. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...